Success is when the time to access an innovative treatment is reduced.
CT-SCOUT™ is a multi-device application aiming at facilitating the recruitment of patients in clinical studies...
It assists the investigational team in detecting the studies for which a patient is potentially eligible according to his/her current health conditions.
Transforms all physician into real time recruiters
Anywhere, anytime
On any device
Easy to use
1. An efficient algorithmic model
2. Real-time detection
3. Simplified
process
Crohn disease
Ulcerative colitis
Psoriasis
Atopic dermatitis
Hidradenitis suppurativa
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
200 +
studies registered (industrial & academic)
1000 +
users registered
170 +
centers in various countries (Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Switzerland, UK…)
7000 +
Patients detected
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor. CT-SCOUT™and ToTem4me facilitate the match between the patients and the studies.
50%
OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
80%
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.
0.02%
OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY
But 80% of patients would accept to participate t a clinical study.
CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
2
WEEKS SET-UP TIME
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
Assist investigational teams in their clinical research activities.
Shorten clinical trials by boosting detection of patients potentially eligible to clinical trials.
Allow patients’ earlier access to innovative and life-saving treatment.
January 30, 2025
MedtechDive Artificial intelligence was a topic of focus for the medical device industry in 2024. Companies including GE Healthcare, Medtronic and Dexcom touted new AI features, and others like Stryker and Quest Diagnostics added AI assets through M&A. Meanwhile, conversations about regulations and generative AI, models that are trained to create new data including images and text, dominated medtech conferences. The Food and Drug Administration recently […]
January 30, 2025
BioPharm International FDA published a final guidance on Jan. 2, 2025 for those interested in participating in the agency’s Advanced Manufacturing Technologies Designation Program, which was developed to facilitate drugs manufactured using advanced manufacturing technologies (AMTs). The guidance, Advanced Manufacturing Technologies Designation Program, is the final version of the draft document issued on Dec. 13, 2023. […]
January 30, 2025
Applied Clinical Trials Online Medable has shared new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT Consortium linking decentralized clinical trial (DCT) approaches to a higher rate in participation across multiple demographic groups. The new research shows that a more strategic implementation of DCT elements, combined with increased regulatory oversight, […]